 | Up a level |
Günther, Gunar; Guglielmetti, Lorenzo; Leu, Claude; Lange, Christoph; van Leth, Frank (2023). Availability and costs of medicines for the treatment of tuberculosis in Europe. Clinical microbiology and infection, 29(1), pp. 77-84. Elsevier 10.1016/j.cmi.2022.07.026
Guglielmetti, Lorenzo; Günther, Gunar; Leu, Claude; Cirillo, Daniela; Duarte, Raquel; Garcia-Basteiro, Alberto L; Goletti, Delia; Jankovic, Mateja; Kuksa, Liga; Maurer, Florian P; Méchaï, Frédéric; Tiberi, Simon; van Leth, Frank; Veziris, Nicolas; Lange, Christoph (2022). Rifapentine access in Europe: growing concerns over key tuberculosis treatment component. The European respiratory journal, 59(5) European Respiratory Society 10.1183/13993003.00388-2022
Heyckendorf, Jan; Marwitz, Sebastian; Reimann, Maja; Avsar, Korkut; DiNardo, Andrew; Günther, Gunar; Hoelscher, Michael; Ibraim, Elmira; Kalsdorf, Barbara; Kaufmann, Stefan H E; Kontsevaya, Irina; van Leth, Frank; Mandalakas, Anna Maria; Maurer, Florian P; Müller, Marius; Nitschkowski, Dörte; Olaru, Ioana D; Popa, Cristina; Rachow, Andrea; Rolling, Thierry; ... (2021). Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model. European respiratory journal, 58(3) European Respiratory Society 10.1183/13993003.03492-2020
Günther, Gunar; Heyckendorf, Jan; Zellweger, Jean Pierre; Reimann, Maja; Claassens, Mareli; Chesov, Dumitru; van Leth, Frank (2021). Defining Outcomes of Tuberculosis (Treatment): From the Past to the Future. Respiration, 100(9), pp. 843-852. Karger 10.1159/000516392
